Press Release: Syndax Pharmaceuticals Appoints Dr. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

Dow JonesMay 12 16:01 ET

Express News | Syndax Pharmaceuticals Appoints DR. Nicholas Botwood as Head of Research and Development and Chief Medical Officer

ReutersMay 12 16:01 ET

Earnings Update: Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Just Reported And Analysts Are Boosting Their Estimates

Simply Wall StMay 8 08:35 ET

Syndax Announces Participation in May Investor Conferences

GlobeNewswireMay 8 07:00 ET

New Analyst Forecast: $SNDX Given 'Sector Perform' Rating

Quiver QuantitativeMay 7 20:27 ET

Syndax Pharma Publishes Data From Pivotal Phase 2 Portion Of AUGMENT-101 Trial Of Revumenib In Patients With R/R MNPM1 Acute Myeloid Leukemia In Blood

BenzingaMay 7 16:03 ET